(MAPS) (2013) 2 of 3

The Multidisciplinary Association for Psychedelic Studies (MAPS) (2013) 2 of 3

The Multidisciplinary Association for Psychedelic Studies (MAPS) is a membership-based 501(c)(3) non-profit research and educational organization working to develop psychedelics and marijuana into legal prescription drugs. MAPS was founded in 1986 by Rick Doblin, and is now based in Santa Cruz, California.

MAPS helps scientists design, fund, and obtain regulatory approval for studies of the safety and effectiveness of a number of currently controlled substances. MAPS works closely with government regulatory authorities worldwide such as the United States Food and Drug Administration (FDA) and the European Medicines Agency (EMEA) to ensure that all of its sponsored research protocols conform to ethical and procedural guidelines for clinical drug research. Included in MAPS’ research efforts are MDMA (Ecstasy) for the treatment of posttraumatic stress disorder (PTSD), LSD and psilocybin for the treatment of anxiety, cluster headaches, and depression associated with end-of-life issues, ibogaine for the treatment of opiate addiction, and alternative delivery systems for medical marijuana such as vaporizers and water pipes. MAPS states that their ultimate goal is to establish a network of clinics where these and other treatments can be provided together with other therapies under the guidance of licensed physicians and therapists.[1]

In addition to its sponsorship of scientific research, MAPS organizes continuing medical education (CME) conferences, sponsors and gives lectures and seminars on the current state of psychedelic and medical marijuana research, participates in community events like music festivals and Burning Man, and publishes a quarterly Bulletin with updates about its ongoing research efforts, legal struggles, and educational initiatives. MAPS has also published a number of books dealing with the history and culture of psychedelic medicine and psychedelic therapy.[2]

Visit: http://www.maps.org/

Video list:

* Fourteen Years of Clinical Research with Ayahuasca - Jordi Riba
* From the Johns Hopkins Psilocybin Findings to the Reconstruction of Religion - Bob Jesse
* Gaultheria Insipida_ A Female Psychedelic Plant from the Andes - Leonardo Rodríguez Pérez
* How Similar to Dreaming is the Ayahuasca Experience_ - Sidarta Ribeiro
* Ibogaine Treatment - Clare Wilkins - Part 1 to 2
* In Search of Entheogenic Molecules_ Phytochemical Analysis from the DMT-Nexus - David Nickles
* Integrating the Modern Practice of Traditional Ayahuasca Shamanism - Joe Tafur
* Jim Fadiman - Psychedelic Research & Creativity Studies at MAPS First Friday Art Tour
* Johns Hopkins Psilocybin Research Project - Roland Griffiths
* Learning from Listening_ Qualitative Data in MDMA-Assisted Psychotherapy Research - Ilsa Jerome
* Linking Ayahuasca, Mental Imagery, & Internal Attention with Neuroimaging - Dráulio Barros de Araujo
* LSD Neuroscience - David E. Nichols
* LSD-Assisted Psychotherapy for Anxiety Secondary to Life Threatening Illness - Peter Gasser
* MAPS - 30 second PSA for the Multidisciplinary Association for Psychedelic Studies
* MAPS Psychedelic Research Presentation at 2011 Womens Visionary Congress
* Marijuana for PTSD_ Existing Evidence and MAPS' FDA-Approved Protocol - Sue Sisley
* MDMA Psychotherapy - Peter Oehen - Part 1 to 2
* MDMA-Assisted Psychotherapy - Research, Results, and Potential
* MDMA-Assisted Psychotherapy for PTSD_ Current Research - Michael Mithoefer & Annie Mithoefer
* Neural Correlates of Altered Consciousness_ Hypnosis, Meditation, & Drug-Based Changes - Amir Raz
* Neurobiology of Psychedelics_ Implication for Mood Disorders - Franz Vollenweider
* Notes on Progress in the New Zealand Ibogaine Study - Geoff Noller
* Pharmacokinetics and Phenomenology of Inhaled Salvinorin A in Humans - Matthew Johnson
* Psilocybin at the End of Life - Charles Grob
* Psilocybin in the Treatment of Smoking Addiction - Albert Garcia-Romeu
* Psilocybin Research - Zeno Sanchez-Ramos - Part 1 to 2
* Psilocybin, Addiction, and End of Life - Stephen Ross
* Psilocybin-Assisted Treatment for Alcohol Dependence - Michael Bogenschutz
* Psilocybin-Facilitated Treatment for Addiction_ Smoking Cessation - Matthew Johnson
* Psychedelic Psychotherapy_ Insights from 25 Years of Research - William Richards
* Psychedelic Research Founders Discussion
* Psychedelic Science 2013 - Participant Stories
* Psychedelic Science 2013_ Conference Welcome - Doblin, Feilding, Jesse, Nichols, Labate
* Psychedelics in Unlocking the Unconscious_ From Cancer to Addiction - Gabor Mate
* Quantitative Analysis of Narrative Reports of Psychedelic Drugs - Matthew Baggott
* Regulations for Drug Research - Amy Emerson & Michelle Weitz - Part 1 of 2